MIFA-Pristone

Today on Post Reports, we take you to an abortion hearing in Amarillo, Tex., that the judge didn’t want you to know was coming. 

Read more:

In a four-hour hearing on Wednesday, U.S. District Judge Matthew Kacsmaryk heard arguments in a lawsuit that could restrict access nationwide to the abortion medication mifepristone. The lawsuit alleges that the medication is unsafe, despite being approved and highly regulated by the FDA for decades. However, many antiabortion activists are hopeful that Kacsmaryk will rule against the FDA, because of his strong religious beliefs and previous support of antiabortion organizations. 

National political reporter Caroline Kitchener was inside the courtroom for the hearing and explains what she heard and what the implications of the ruling could be.